NSE - Delayed Quote INR
Bliss GVS Pharma Limited (BLISSGVS.NS)
121.87
-4.51
(-3.57%)
At close: April 25 at 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
1,524,486
343,135
1,354,806
639,694
Investing Cash Flow
--
-1,328,218
-77,509
-929,751
-469,910
Financing Cash Flow
--
-208,930
-249,385
-237,301
-207,980
End Cash Position
--
235,906
250,069
219,871
131,345
Capital Expenditure
--
-283,293
-937,990
-740,031
-91,242
Issuance of Capital Stock
--
23,140
20,415
22,844
--
Issuance of Debt
--
154,884
400,221
107,555
96,650
Repayment of Debt
--
-243,842
-538,953
-263,612
-163,418
Free Cash Flow
--
1,241,193
-594,855
614,775
548,452
3/31/2021 - 7/26/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LASA.NS Lasa Supergenerics Limited
17.22
-3.53%
BALPHARMA.BO Bal Pharma Limited
107.51
-1.02%
INDSWFTLTD.NS Ind-Swift Limited
13.00
-2.91%
LASA.BO Lasa Supergenerics Limited
17.20
-3.91%
ZENOTECH.BO Zenotech Laboratories Limited
58.01
-1.71%
AMBALALSA.BO Ambalal Sarabhai Enterprises Limited
37.95
-3.75%
ALPA.NS Alpa Laboratories Limited
108.16
-4.70%
MANGALAM.NS Mangalam Drugs & Organics Limited
80.25
-3.34%
WANBURY.NS Wanbury Limited
255.88
-7.58%
INDSWFTLAB.NS Ind-Swift Laboratories Limited
80.51
-6.17%